Literature DB >> 27861288

Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.

Ling Lu1, Haoming Zhou, Ming Ni, Xuehao Wang, Ronald Busuttil, Jerzy Kupiec-Weglinski, Yuan Zhai.   

Abstract

Liver ischemia reperfusion activates innate immune system to drive the full development of inflammatory hepatocellular injury. Damage-associated molecular patterns (DAMPs) stimulate myeloid and dendritic cells via pattern recognition receptors (PRRs) to initiate the immune response. Complex intracellular signaling network transduces inflammatory signaling to regulate both innate immune cell activation and parenchymal cell death. Recent studies have revealed that DAMPs may trigger not only proinflammatory but also immune regulatory responses by activating different PRRs or distinctive intracellular signaling pathways or in special cell populations. Additionally, tissue injury milieu activates PRR-independent receptors which also regulate inflammatory disease processes. Thus, the innate immune mechanism of liver ischemia-reperfusion injury involves diverse molecular and cellular interactions, subjected to both endogenous and exogenous regulation in different cells. A better understanding of these complicated regulatory pathways/network is imperative for us in designing safe and effective therapeutic strategy to ameliorate liver ischemia-reperfusion injury in patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27861288      PMCID: PMC5141614          DOI: 10.1097/TP.0000000000001411

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  128 in total

1.  Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages.

Authors:  Ingo Klein; Judith C Cornejo; Noelle K Polakos; Beena John; Sherry A Wuensch; David J Topham; Robert H Pierce; Ian Nicholas Crispe
Journal:  Blood       Date:  2007-08-09       Impact factor: 22.113

2.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

3.  Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.

Authors:  Hai Huang; Samer Tohme; Ahmed B Al-Khafaji; Sheng Tai; Patricia Loughran; Li Chen; Shu Wang; Jiyun Kim; Timothy Billiar; Yanming Wang; Allan Tsung
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

4.  Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling.

Authors:  Toshiyuki Yano; Marcella Ferlito; Angel Aponte; Atsushi Kuno; Tetsuji Miura; Elizabeth Murphy; Charles Steenbergen
Journal:  Circ Res       Date:  2014-02-20       Impact factor: 17.367

5.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

6.  Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.

Authors:  Justin D Ellett; Zachary P Evans; Carl Atkinson; Michael G Schmidt; Rick G Schnellmann; Kenneth D Chavin
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

7.  Distinct development and functions of resident and recruited liver Kupffer cells/macrophages.

Authors:  Masami Ikarashi; Hiroyuki Nakashima; Manabu Kinoshita; Atsushi Sato; Masahiro Nakashima; Hiromi Miyazaki; Kiyoshi Nishiyama; Junji Yamamoto; Shuhji Seki
Journal:  J Leukoc Biol       Date:  2013-08-20       Impact factor: 4.962

8.  CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.

Authors:  Guo-Yun Chen; Jie Tang; Pan Zheng; Yang Liu
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

9.  ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury.

Authors:  Naoko Kamo; Bibo Ke; Amir A Ghaffari; Xiu-da Shen; Ronald W Busuttil; Genhong Cheng; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2013-05-15       Impact factor: 17.425

10.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

View more
  48 in total

Review 1.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

2.  Recipient HO-1 inducibility is essential for posttransplant hepatic HO-1 expression and graft protection: From bench-to-bedside.

Authors:  Shoichi Kageyama; Hirofumi Hirao; Kojiro Nakamura; Bibo Ke; Min Zhang; Takahiro Ito; Antony Aziz; Damla Oncel; Fady M Kaldas; Ronald W Busuttil; Rebecca A Sosa; Elaine F Reed; Jesus A Araujo; Jerzy W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2018-08-24       Impact factor: 8.086

Review 3.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

4.  Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury.

Authors:  Yuan Liu; Tianfei Lu; Cheng Zhang; Zhengze Xue; Jin Xu; Ronald W Busuttil; Qiang Xia; Ning Xu; Jerzy W Kupiec-Weglinski; Haofeng Ji
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

5.  Anti-interferon-α receptor 1 antibodies attenuate inflammation and organ injury following hemorrhagic shock.

Authors:  Joaquin Cagliani; Weng-Lang Yang; Joseph T McGinn; Zhimin Wang; Ping Wang
Journal:  J Trauma Acute Care Surg       Date:  2019-05       Impact factor: 3.313

6.  Inositol 1,4,5-trisphosphate receptor type 3 plays a protective role in hepatocytes during hepatic ischemia-reperfusion injury.

Authors:  Antônio Carlos Melo Lima Filho; Andressa França; Rodrigo M Florentino; Marcone Loiola Dos Santos; Fernanda de Oliveira Lemos; Dabny Goulart Missiaggia; Roberta Cristelli Fonseca; André Gustavo Oliveira; Meenakshisundaram Ananthanarayanan; Mateus T Guerra; Matheus de Castro Fonseca; Paula Vieira Teixeira Vidigal; Cristiano Xavier Lima; Michael H Nathanson; M Fatima Leite
Journal:  Cell Calcium       Date:  2020-08-11       Impact factor: 6.817

7.  DNAX Activating Protein of 12 kDa/Triggering Receptor Expressed on Myeloid Cells 2 Expression by Mouse and Human Liver Dendritic Cells: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury.

Authors:  Toshimasa Nakao; Yoshihiro Ono; Helong Dai; Ryosuke Nakano; Angelica Perez-Gutierrez; Geoffrey Camirand; Hai Huang; David A Geller; Angus W Thomson
Journal:  Hepatology       Date:  2019-02-19       Impact factor: 17.425

Review 8.  Danger signals in liver injury and restoration of homeostasis.

Authors:  Hui Han; Romain Desert; Sukanta Das; Zhuolun Song; Dipti Athavale; Xiaodong Ge; Natalia Nieto
Journal:  J Hepatol       Date:  2020-05-01       Impact factor: 25.083

9.  IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation.

Authors:  Hamza O Yazdani; Hui-Wei Chen; Samer Tohme; Sheng Tai; Dirk J van der Windt; Patricia Loughran; Brian R Rosborough; Vikas Sud; Donna Beer-Stolz; Heth R Turnquist; Allan Tsung; Hai Huang
Journal:  J Hepatol       Date:  2017-09-21       Impact factor: 25.083

Review 10.  Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury.

Authors:  Margarida Ferreira-Silva; Catarina Faria-Silva; Pedro Viana Baptista; Eduarda Fernandes; Alexandra Ramos Fernandes; Maria Luísa Corvo
Journal:  Drug Deliv Transl Res       Date:  2021-03-03       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.